Loading clinical trials...
Loading clinical trials...
The goals of the proposed research are to first determine the minimal and/or optimal dose of a digital intervention required for cognitive enhancement, and then to examine the impact of several potent...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of California, San Francisco
Collaborators
NCT06223672 · Cognitive Decline, Cognitive Impairment
NCT05336188 · Opioid-Related Disorders, Mobile Applications, and more
NCT07087418 · Digestive Diseases, Radiology, and more
NCT06501495 · Aging, Alzheimer Disease
NCT07101380 · Mild Cognitive Impairment (MCI)
University of California San Francisco
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions